Published in Br Heart J on January 01, 1988
Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction. Br Heart J (1990) 1.54
Multiple microemboli after disintegration of clot during thrombolysis for acute myocardial infarction. BMJ (1989) 1.39
A new skin lesion associated with intravenous streptokinase. BMJ (1993) 1.21
Recurrence of a reactive arthritis following streptokinase therapy. Postgrad Med J (1991) 0.75
Iritis after treatment with streptokinase. BMJ (1994) 0.75
The first case of Henoch-Schonlein purpura associated with rosuvastatin: colonic involvement coexisting with small intestine. BMJ Case Rep (2014) 0.75
Rash after treatment with anistreplase. Br Heart J (1990) 0.75
Intravenous streptokinase in evolving acute myocardial infarction. Am J Cardiol (1984) 2.08
Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction. Eur Heart J (1984) 1.72
Leukocytoclastic vasculitis. Arch Dermatol (1976) 1.52
Serum sickness following streptokinase therapy. AJR Am J Roentgenol (1982) 1.49
Serum sickness-like illness and leukocytoclastic vasculitis following intracoronary arterial streptokinase. Am Heart J (1987) 1.41
Crescentic glomerulonephritis: a possible complication of streptokinase treatment for myocardial infarction. Br Heart J (1986) 1.33
Intravenous versus intracoronary streptokinase in acute myocardial infarction. Am J Cardiol (1985) 1.00
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol (1993) 6.55
Staffing and facilities in cardiology in England and Wales July 1982. Second biennial survey. Br Heart J (1983) 4.86
Emergency medical treatment of anaphylactic reactions. Project Team of the Resuscitation Council (UK) J Accid Emerg Med (1999) 4.03
A community training scheme in cardiopulmonary resuscitation. Br Med J (Clin Res Ed) (1984) 3.83
Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant (1996) 3.51
Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am J Respir Crit Care Med (2001) 3.26
Association between particulate- and gas-phase components of urban air pollution and daily mortality in eight Canadian cities. Inhal Toxicol (2000) 2.88
Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. American Heart Association. Circulation (1997) 2.68
Staffing and facilities in cardiology in the United Kingdom 1984. Third biennial survey. Br Heart J (1986) 2.44
Associations between ambient particulate sulfate and admissions to Ontario hospitals for cardiac and respiratory diseases. Am J Epidemiol (1995) 2.40
Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Br Med J (Clin Res Ed) (1986) 2.33
Occupational exposure to carcinogens in the European Union. Occup Environ Med (2000) 2.18
Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. Eur Heart J (1990) 2.17
The 1998 European Resuscitation Council guidelines for adult single rescuer basic life support: A statement from the Working Group on Basic Life Support, and approved by the executive committee. Resuscitation (1998) 2.06
A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant (1991) 1.87
Coronary angioplasty versus medical therapy for angina. Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial. Eur Heart J (2002) 1.83
Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol (1998) 1.72
Five hundred patients with myocardial infarction monitored within one hour of symptoms. Br Med J (Clin Res Ed) (1983) 1.71
Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. Am J Pathol (1998) 1.70
The association between ambient carbon monoxide levels and daily mortality in Toronto, Canada. J Air Waste Manag Assoc (1998) 1.70
Associations between daily cause-specific mortality and concentrations of ground-level ozone in Montreal, Quebec. Am J Epidemiol (2001) 1.69
The medical and economic impact of laparoscopically assisted vaginal hysterectomy in a large, metropolitan, not-for-profit hospital. Am J Obstet Gynecol (1995) 1.67
Patients' interpretation of symptoms as a cause of delay in reaching hospital during acute myocardial infarction. Heart (2000) 1.67
Hearing conservation for farmers: source apportionment of occupational and environmental factors contributing to hearing loss. J Occup Environ Med (2000) 1.66
Identification of persons with cardiorespiratory conditions who are at risk of dying from the acute effects of ambient air particles. Environ Health Perspect (2001) 1.65
International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: the Thrombolysis in Cardiac Arrest (TROICA) Study. Eur J Clin Invest (2005) 1.64
Population effects of the bombing of Oklahoma City. J Okla State Med Assoc (1999) 1.63
Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.61
Optimal Response to Cardiac Arrest study: defibrillation waveform effects. Resuscitation (2001) 1.61
Oligodendroglial development in human fetal cerebrum. Ann Neurol (1995) 1.58
The association between daily mortality and ambient air particle pollution in Montreal, Quebec. 2. Cause-specific mortality. Environ Res (2001) 1.53
Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung. J Clin Oncol (1984) 1.51
Resuscitation. New advisory statements on life support have been published. BMJ (1997) 1.48
Treatment for amblyopia: results using occlusive contact lens. J Pediatr Ophthalmol Strabismus (1997) 1.43
Barriers to optimum management of heart failure by general practitioners. Br J Gen Pract (1999) 1.42
Particulate matter induces cytokine expression in human bronchial epithelial cells. Am J Respir Cell Mol Biol (2001) 1.42
The 1998 European Resuscitation Council guidelines for adult advanced life support: A statement from the Working Group on Advanced Life Support, and approved by the executive committee. Resuscitation (1998) 1.39
Contact dermatitis to nasturtium. Br J Dermatol (1997) 1.39
Multiple microemboli after disintegration of clot during thrombolysis for acute myocardial infarction. BMJ (1989) 1.39
Diagnosing an MI: don't trust the monitor! Heart (2010) 1.38
Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Respir Cell Mol Biol (1998) 1.33
Use of an automated external defibrillator-pacemaker by ambulance staff. Lancet (1982) 1.33
Assessment of the practicality and safety of thrombolysis with anistreplase given by general practitioners. Br J Gen Pract (1995) 1.32
European Resuscitation Council Guidelines 2000 for Adult Advanced Life Support. A statement from the Advanced Life Support Working Group(1) and approved by the Executive Committee of the European Resuscitation Council. Resuscitation (2001) 1.29
The use of spontaneous language measures as criteria for identifying children with specific language impairment: an attempt to reconcile clinical and research incongruence. J Speech Hear Res (1996) 1.28
The effect of repeated exposure to particulate air pollution (PM10) on the bone marrow. Am J Respir Crit Care Med (2001) 1.27
Zinc is the toxic factor in the lung response to an atmospheric particulate sample. Toxicol Appl Pharmacol (2000) 1.25
A micromethod for the quantitation of cellular proteins in Percoll with the Coomassie brilliant blue dye-binding assay. Anal Biochem (1983) 1.23
Artefactual ST segment abnormalities due to electrocardiograph design. Br Heart J (1985) 1.23
Simple mechanical methods for cardioversion: defence of the precordial thump and cough version. Br Med J (Clin Res Ed) (1985) 1.22
Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital "Utstein style". American Heart Association. Ann Emerg Med (1997) 1.21
Lung cancer practice guidelines: lessons learned and issues addressed by the Ontario Lung Cancer Disease Site Group. J Clin Oncol (1997) 1.21
Improved functional recovery of denervated skeletal muscle after temporary sensory nerve innervation. Neuroscience (2001) 1.15
Myocardial and skeletal muscle concentrations of digoxin in patients on long-term therapy. Br Med J (1972) 1.14
An anomalous muscle in the region of the popliteal fossa: case report. J Anat (1998) 1.14
Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. Obstet Gynecol (2001) 1.11
Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants. J Thromb Haemost (2006) 1.10
Effect of chemotherapy on the duration of diarrhoea, and on vibrio excretion by cholera patients. J Trop Med Hyg (1971) 1.09
Out-of-hospital resuscitation in East Sussex: 1981 to 1989. Br Heart J (1993) 1.08
Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer. J Clin Oncol (1999) 1.08
An optimized protein in-gel digest method for reliable proteome characterization by MALDI-TOF-MS analysis. Anal Biochem (2005) 1.07
The Universal ALS algorithm. An advisory statement by the Advanced Life Support Working Group of the International Liaison Committee on Resuscitation. Resuscitation (1997) 1.07
Electrical pacing in heart block complicating acute myocardial infarction. Br Heart J (1970) 1.06
Psychogenic parasitosis. A case series and literature review. Psychosomatics (1999) 1.05
Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation (1997) 1.04
Questionable relation of aryl hydrocarbon hydroxylase to lung-cancer risk. N Engl J Med (1977) 1.03
Effects of serum protein and colloid on the alamarBlue assay in cell cultures. Toxicol In Vitro (1995) 1.02
Primary pleural epithelioid haemangioendothelioma with metastases to the skin. A case report and literature review. J Clin Pathol (2005) 1.01
Pulmonary toxicity of an atmospheric particulate sample is due to the soluble fraction. Toxicol Appl Pharmacol (1999) 1.00
Delay times in the administration of thrombolytic therapy: the Brighton experience. Int J Cardiol (1995) 1.00
Drug treatment of arrhythmias during cardiopulmonary resuscitation. A statement for the Advanced Life Support Working Party of the European Resuscitation Council. Resuscitation (1992) 1.00
Cytotoxicity of ambient air particles to rat lung macrophages: Comparison of cellular and functional assays. Toxicol In Vitro (1996) 1.00
Upregulation of T-helper 1 cytokines and chemokine expression in post-transplant airway obliteration. Am J Respir Crit Care Med (1999) 0.99
Randomised controlled trials of staged teaching for basic life support. 1. Skill acquisition at bronze stage. Resuscitation (2000) 0.98
Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in Uganda. J Infect Dis (2000) 0.97
Adenovirus-mediated interleukin-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliterans. Hum Gene Ther (1998) 0.97
Sternal fracture: what investigations are indicated? Injury (1993) 0.97
Radiographic evaluation of the effect of initial periodontal therapy on thickness of the maxillary sinus mucosa. J Periodontol (1988) 0.96
A rationale for staged teaching of basic life support. Resuscitation (1998) 0.96
Defibrillation at a football stadium: an experiment with Brighton and Hove Albion. Br Med J (Clin Res Ed) (1982) 0.96
Pulmonary oedema without critical increase in left atrial pressure in acute myocardial infarction. Br Med J (Clin Res Ed) (1981) 0.95
Staffing in cardiology in the United Kingdom 1988: Fifth biennial survey. Br Heart J (1990) 0.95
Isoxsuprine-induced release of pulmonary surfactant in the rabbit fetus. Am J Obstet Gynecol (1977) 0.95
Frequency analysis of the P wave: comparative techniques. Pacing Clin Electrophysiol (1995) 0.94
Fax machines for thrombolysis? Heart (1997) 0.94
Special resuscitation situations: an advisory statement from the International Liaison Committee on Resuscitation. Circulation (1997) 0.93
Adjustment of the osmolality of Percoll for the isopycnic separation of cells and cell organelles. Anal Biochem (1984) 0.93
Pulmonary hypoplasia in babies with severe rhesus isoimmunisation: a quantitative study. J Pathol (1977) 0.93
Signal distortion in the electrocardiogram due to inadequate phase response. IEEE Trans Biomed Eng (1983) 0.92
Thyrotoxic myopathy presenting as dysphagia. Postgrad Med J (1980) 0.91
Phagocytosis of particulate air pollutants by human alveolar macrophages stimulates the bone marrow. Am J Physiol Lung Cell Mol Physiol (2000) 0.91
Differential transcriptional activities of HLA-DR genes in the various haplotypes. J Immunol (1994) 0.91
Staging and prognostic factors in small cell carcinoma of the lung. Cancer Treat Rep (1983) 0.90
Cystic change (pseudocavitation) associated with bronchioloalveolar carcinoma: a report of four patients. J Thorac Imaging (1995) 0.90
Single lead atrial synchronised pacing in patients with cardiogenic shock after acute myocardial infarction. Br Heart J (1984) 0.90